Even in Denmark — Novo Nordisk's household current market — an application for Wegovy to get public overall health insurance coverage was rejected over the grounds that its cost was incommensurate with its therapeutic price. The region's largest private well being insurance provider, Danmark, also announced that it would cease https://hermannq258ahn9.wikilowdown.com/user